Evonetix
Evonetix is a pioneer of groundbreaking gene synthesis technology. Their benchtop platform provides the ability to synthesize gene-length DNA at unprecedented accuracy, scale and speed, freeing scientists from the constraints of existing technology to tackle the world’s most pressing challenges across healthcare, agriculture, manufacturing and sustainability.
Latest Evonetix Content
Product News
Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform With Analog Devices
The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines.
Product News
Evonetix Places First DNA Synthesis Development Platform at Imperial College London
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.
Product News
Evonetix Commences Early Access Program for DNA Synthesized by Thermal Control on its Semiconductor Chip
EVONETIX LTD today announced the opening of its early access program for semiconductor synthesized DNA.
Product News
Evonetix Appoints Colin McCracken as Chief Executive Officer
EVONETIX LTD, the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.
Product News
Evonetix Granted Patent for Technology Enabling Thermally-Controlled DNA Synthesis
EVONETIX LTD has announced it has been granted patent EP3551331B1 in Europe for its proprietary thermal control technology for DNA synthesis, as well as the design and manufacture of its silicon chips.
Advertisement
